Future Directions in Cardio-Oncology
References
- Jaiswal S Natarajan P Silver AJ Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease N Engl J Med 2017 Jul 13 377 2 111 21
- Aminkeng F Ross CJ Rassekh SR ; CPNDS Clinical Practice Recommendations Group Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity Br J Clin Pharmacol 2016 Sep 82 3 683 95
- Garcia-Pavia P Kim Y Alejandra Restrepo-Cordoba M Genetic Variants Associated with Cancer Therapy-Induced Cardiomyopathy Circulation 2019 Jul 2 140 1 21 41
- Todorova VK Makhoul I Wei J Klimberg VS Circulating miRNA Profiles of Doxorubicin-induced Cardiotoxicity in Breast Cancer Patients Ann Clin Lab Sci 2017 Mar 47 2 115 119
- Gupta SK Garg A Bar C Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression Circ Res 2018 Jan 19 122 2 246 254
- Burridge PW Li YF Matsa E Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity Nat Med 2016 May 22 5 547 56
- Yeh ETH Chang HM Oncocardiology—Past, Present, and Future JAMA Cardiol 2016 Dec 1 1 9 1066 72
- Galan-Arriola C Lobo M Vilchez-Tschischke JP Serial magnetic resonance imaging to identify early stages of anthracycline-induced cardiotoxicity J Am Coll Cardiol 2019 Feb 26 73 7 779 791
-
Drafts
BC
Twomley
KM
D'Agostino
R
Jr Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease JACC Cardiovasc Imaging 2013 Aug 6 8 877 85 - Jordan JH Castellino SM Melendez GC Left ventricular mass change after anthracycline chemotherapy Circ Heart Fail 2018 Jul 11 7 e004560
- Sarocchi M Bauckneht M Arboscello E An increase in myocardial 18-fluorodeoxyglucose uptake is associated with left ventricular ejection fraction decline in Hodgkin lymphoma patients treated with anthracycline J Transl Med 2018 Oct 25 16 1 295
- Bauckneht M Ferrarazzo G Fiz F Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: A Translational 18F-FDG PET/CT Observation J Nucl Med 2017 Oct 58 10 1638 1645
- Psaltis PJ Carbone A Nelson AJ Reparative effects of allogeneic mesenchymal precursor cells delivered transendocardially in experimental nonischemic cardiomyopathy JACC Cardiovasc Interv 2010 Sep 3 9 974 83
- Bolli R Hare JM Henry TD Cardiovascular Cell Therapy Research Network (CCTRN) Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial Am Heart J 2018 Jul 201 54 62
DOI: https://doi.org/10.14797/mdcvj.935 | Journal eISSN: 1947-6108
Language: English
Page range: 300 - 302
Published on: Oct 1, 2011
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2011 Barry H. Trachtenberg, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.